Ranked #1
FDA Wants Industry to Guard Against Cybersecurity Risks of Medical Devices
FDA Wants Industry to Guard Against Cybersecurity Risks of Medical Devices
As medical device makers are building network connectivity and intelligence into their products, they are adding new vul... Read more
21 Jan 2016
•
22mins
Ranked #2
CrowdMed Enlists the Wisdom of Crowds to Solve Medical Mysteries
CrowdMed Enlists the Wisdom of Crowds to Solve Medical Mysteries
For many patients with rare and difficult to diagnose conditions, it can take many years and many doctors to find a corr... Read more
9 Jul 2015
•
19mins
Similar Podcasts
The Readout Loud
The Long Run with Luke Timmerman
FYI - For Your Innovation
Inside the Strategy Room
BioCentury This Week
Masters of Scale
Business Of Biotech
Biotech 2050 Podcast
Motley Fool Money
a16z Podcast
Goldman Sachs Exchanges
Azeem Azhar's Exponential View
Masters in Business
What Goes Up
WSJ’s The Future of Everything
Ranked #3
Jimmy Carter’s Final Wish: Eradicating Guinea Worm
Jimmy Carter’s Final Wish: Eradicating Guinea Worm
President Jimmy Carter, at a recent press conference discussing his cancer diagnosis and treatment, expressed his wish t... Read more
27 Aug 2015
•
19mins
Ranked #4
Enlisting the Immune System in the Battle Against Alzheimer’s
Enlisting the Immune System in the Battle Against Alzheimer’s
Alzheimer’s disease is the sixth leading cause of death and it continues to rise. Today it is costing the U.S. healthcar... Read more
8 Jun 2017
•
18mins
Most Popular Podcasts
The Joe Rogan Experience
TED Talks Daily
The Tim Ferriss Show
The Daily
Stuff You Should Know
Oprah's SuperSoul Conversations
Armchair Expert with Dax Shepard
Ranked #5
Overcoming the Delivery Challenges of Gene Therapy
Overcoming the Delivery Challenges of Gene Therapy
Gene therapy represents an expanding area of potential to correct and modulate the activities of genes driving diseases.... Read more
1 Jun 2017
•
17mins
Ranked #6
Why Big Pharma Hasn’t Been Able to Fix Its Revenue Gap with M&A
Why Big Pharma Hasn’t Been Able to Fix Its Revenue Gap with M&A
It was an unprecedented year for M&A activity in the life sciences, but even though Big Pharma returned to dealmakin... Read more
22 Jan 2015
•
17mins
Ranked #7
Should Investors Temper Their Enthusiasm for CAR-T Therapies
Should Investors Temper Their Enthusiasm for CAR-T Therapies
CAR-T cell immunotherapies seek to harness the body’s immune system to fight tumor cells. The promise of this new class ... Read more
5 Feb 2015
•
24mins
Ranked #8
Why Life Sciences M&A Should Heat up This Year
Why Life Sciences M&A Should Heat up This Year
A surge in merger and acquisition activity in the life sciences is expected this year, according to a new report from EY... Read more
11 Jan 2018
•
19mins
Ranked #9
Carrying Therapeutic Payloads Across the Blood-Brain Barrier
Carrying Therapeutic Payloads Across the Blood-Brain Barrier
The blood-brain barrier provides essential protection against pathogens while allowing needed oxygen and nutrients to pa... Read more
12 Jul 2018
•
24mins
Ranked #10
What a Decade of Investment Tells Us about the Health of Biotech
What a Decade of Investment Tells Us about the Health of Biotech
A detailed view of funding of emerging therapeutic companies over the past ten years shows despite a rebound in venture ... Read more
25 Jun 2015
•
14mins
Ranked #11
What’s in Store for the Biotech Industry in 2015
What’s in Store for the Biotech Industry in 2015
As the biotech industry ramps up for the JPMorgan Healthcare conference, we continue our conversation with TheStreet.com... Read more
31 Dec 2014
•
18mins
Ranked #12
Turning Cold Tumors Hot
Turning Cold Tumors Hot
One reason immunotherapies fail is because of the ability to tumors to alter the microenvironment in which they exist an... Read more
9 Jan 2020
•
22mins
Ranked #13
Regeneron Embraces Genetics as Fundamental to Drug Development
Regeneron Embraces Genetics as Fundamental to Drug Development
Drug discovery and development is a slow and costly process, but the Regeneron Genetics Center represents a drugmakers’ ... Read more
19 Jan 2017
•
32mins
Ranked #14
Our Annual Biotech Review/Preview with STAT’s Adam Feuerstein
Our Annual Biotech Review/Preview with STAT’s Adam Feuerstein
A holiday tradition at The Bio Report is to take a moment to reflect on the year past and look ahead to the new year wit... Read more
26 Dec 2019
•
26mins
Ranked #15
The Year in Biotech and What to Watch in 2019
The Year in Biotech and What to Watch in 2019
As the year draws to a close, we continue what’s become an annual tradition and look back on the year in biotech and ahe... Read more
27 Dec 2018
•
25mins
Ranked #16
Biotech Industry Moves Towards a Patent Cliff
Biotech Industry Moves Towards a Patent Cliff
Scrutiny of drug prices around the globe is expected to exert growing pressure on the biopharmaceutical sector. Evaluate... Read more
13 Jul 2017
•
14mins
Ranked #17
Why the Diversity of Genomic Data Matters
Why the Diversity of Genomic Data Matters
The lack of diversity in genomic data has been an issue of growing concern. It threatens to limit the benefits from the ... Read more
17 May 2018
•
32mins
Ranked #18
Why Biomarkers May Be the Key to Immuno-Oncology Success
Why Biomarkers May Be the Key to Immuno-Oncology Success
Developers of cancer immunotherapies are in a race to find combinations that can distinguish their products for specific... Read more
10 May 2018
•
26mins
Ranked #19
Shaping the Emerging Bioeconomy
Shaping the Emerging Bioeconomy
The ability to engineer biological systems to replace chemical processes is making the promise of the emerging bioeconom... Read more
7 Nov 2019
•
27mins
Ranked #20
Why Drug Companies May Soon Become Health Technology Companies
Why Drug Companies May Soon Become Health Technology Companies
The convergence of technology and life sciences, changing consumer behavior, and increasing pricing pressures on drug an... Read more
15 Mar 2018
•
24mins
